Including older adults in cancer research: Perspectives across the trial spectrum
SIOG Head Office2026-09-25T13:08:38+02:00Organised by SIOG September 24, 2026 https://www.youtube.com/watch?v=hce8YSuHAAQ
Organised by SIOG September 24, 2026 https://www.youtube.com/watch?v=hce8YSuHAAQ
Organised by the SIOG Methods Working Group September 17, 2026 http://youtube.com/watch?v=0J8T_YwlZKY
Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.
Organised by SIOG August 5, 2026 https://youtu.be/Lw_-HzdB3IU
Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.
Organised by the SIOG Methods Working Group June 25, 2026 https://youtu.be/HqwDJDlFrnw
Geneva/Tianjin 19 May 2026 - The International Society of Geriatric Oncology (SIOG) and the China Anti-Cancer Association (CACA) have signed a Memorandum of Understanding (MoU) establishing a framework for cooperation in oncology care for older adults. The agreement aims to strengthen coordination, promote education, enhance scientific exchange, and support the global development of geriatric oncology. Through this partnership, SIOG and CACA will collaborate on academic activities, international congresses, expert engagement, scientific programs, and publication opportunities. Key areas of cooperation include the mutual promotion of major events, co-hosted webinars, summits, symposia and workshops – such as the recently concluded CACA-SIOG Virtual Summit 2026 in April 30 and a planned CACA-SIOG Symposium during the 2026 China Congress of Holistic Integrative Oncology in Changsha, Hunan Province, PRC. The MoU also encourages manuscript submissions by SIOG experts to the Holistic Integrative Oncology Journal and explores opportunities for qualified SIOG experts to join the journal’s [...]
Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.
Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.
Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.
International Society of Geriatric Oncology
P/A Comptabilis
9 route des Jeunes
1227 Les Acacias - Switzerland
In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).
Powered by K.I.T. Group – Crafted for Excellence